UPU-26134-39903 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-24
Dose 1 — Moderna
2022-06-29
Registered in v-safe
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-07-01
Survey response — day 7, dose 1, under 3
MedDRA: Nasal congestion — Feeling: Good · Irritability/crying

Free text: Stuffy nose

MedDRA releases: 2024-11 · check-in free text available
2022-07-08
Survey response — day 14, dose 1, under 3
MedDRA: Cough, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school

Free text: Fever, cough, congestion

MedDRA releases: 2024-11 · check-in free text available
2022-07-15
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-22
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-29
Health check-in — day 35, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-07-30
Dose 2 — Moderna
2022-08-05
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-08-06
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-13
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-22
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-27
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-03
Survey response — day 35, dose 2, under 3
MedDRA: Cough, Nasal congestion — Feeling: Fair

Free text: Cough, nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-09-10
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-29
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-28
Survey response — 6 months, dose 2, under 3
MedDRA: Conjunctivitis viral, Ear infection, Office visit, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-01-28
Report sent to call center — 6 months, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2023-01-30
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-24	Moderna	No
2	2022-07-30	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2023-01-28	Successful 2023-01-30	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — day 7, dose 1, under 3

2022-07-01

Systemic reaction (other): Stuffy nose

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-08

Symptoms: Fever, cough, congestion

Release 12 (Under 3) — day 35, dose 2, under 3

2022-09-03

Symptoms: Cough, nasal congestion

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Conjunctivitis viral	·	·	✓
SD	Cough	·	·	✓
SD	Ear infection	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SRO	Nasal congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release